
The partnership with University of Oxford’s Jenner Institute consists of a two-fold donation, comprising an immediate financial contribution to be invested in the scientists at the heart of vaccine research, and the creation of the Bvlgari Scholarship to fund PhD studies in epidemiology. Emergency vaccine development in particular is a key pillar of Oxford’s reputation, thanks to a combination of scientific expertise and agile response and technical capabilities usually only found in pharmaceutical companies. Yet the University’s programme to rapidly develop a vaccine against COVID-19 – making Oxford’s vaccine trial one of the most advanced in the world – brings with it the need for equally ambitious and boundary-pushing scientific equipment.